These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 31369289)
1. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4. Niu J; Li Z; Li F Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289 [TBL] [Abstract][Full Text] [Related]
2. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma. Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377 [TBL] [Abstract][Full Text] [Related]
4. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC. Xu G; Wei X; Tu Q; Zhou C Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620 [TBL] [Abstract][Full Text] [Related]
5. miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1. Lu W; Hu Y; Ma Q; Zhou L; Jiang L; Li Z; Zhao S; Xu Y; Shi W; Li S; Liu Y Oncotarget; 2016 Sep; 7(38):62364-62376. PubMed ID: 27577078 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Ye YY; Mei JW; Xiang SS; Li HF; Ma Q; Song XL; Wang Z; Zhang YC; Liu YC; Jin YP; Hu YP; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu YB Cell Death Dis; 2018 Mar; 9(3):410. PubMed ID: 29540696 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE. Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841 [TBL] [Abstract][Full Text] [Related]
9. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer. Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047 [TBL] [Abstract][Full Text] [Related]
10. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway. Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2. Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Hu J; Shen H; Chen Z; Yin B; Ma B Int J Oncol; 2014 Jun; 44(6):2050-8. PubMed ID: 24682444 [TBL] [Abstract][Full Text] [Related]
12. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer. Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112 [TBL] [Abstract][Full Text] [Related]
13. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma. Sun Y; Zhang L; Zhang S Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394 [TBL] [Abstract][Full Text] [Related]
14. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer. Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Pan W; Wang H; Jianwei R; Ye Z Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602 [TBL] [Abstract][Full Text] [Related]
16. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer. He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245 [TBL] [Abstract][Full Text] [Related]
17. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling. Yan X; Yang P; Liu H; Zhao Y; Wu Z; Zhang B Cell Cycle; 2022 Jun; 21(11):1166-1177. PubMed ID: 35196196 [TBL] [Abstract][Full Text] [Related]
18. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199 [TBL] [Abstract][Full Text] [Related]
19. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2. Li XL; Li SZ; Wu CX; Xing XH Kaohsiung J Med Sci; 2021 Apr; 37(4):294-304. PubMed ID: 33236530 [TBL] [Abstract][Full Text] [Related]
20. MiR-20a triggers metastasis of gallbladder carcinoma. Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]